Thrombolysis in patients with diabetes

BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6985.1008a (Published 15 April 1995) Cite this as: BMJ 1995;310:1008

More evidence that the treatment should not necessarily be withheld

  1. D K Newman,
  2. M P Snead,
  3. D W Flanagan,
  4. J D Scott
  1. Registrar in ophthalmology Senior registrar in ophthalmology Consultant ophthalmologist Consultant ophthalmologist Department of Ophthalmology, Addenbrooke's Hospital, Cambridge CB2 2QQ

    EDITOR,—Helen Ward and John S Yudkin rightly draw attention to the lack of evidence that thrombolytic treatment for acute myocardial infarction may precipitate vitreous haemorrhage in patients with diabetic retinopathy.1 Two additional points strengthen their argument that the treatment should not necessarily be withheld in such patients.

    Firstly, consideration of the pathophysiology of diabetic vitreous haemorrhage …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription